U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Datopotamab Deruxtecan
GD2OWY1DTK
US Approved Rx (2025)
First approved in 2025
General
Names
11
Identifiers
6
Subunits
4
Related Substances
2
Datopotamab Deruxtecan
GD2OWY1DTK
US Approved Rx (2025)
First approved in 2025
General
Approval Year
2025
68
Names
11
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
DATO-DXD
Preferred Name
English
Datopotamab Deruxtecan
Official Name
English
DS-1062
Code
English
datopotamab deruxtecan [INN]
Common Name
English
Immunoglobulin G1, anti-(human tumor-associated calcium signal transducer 2) (human-Mus musculus monoclonal MAAP-9001 ?1-chain), compd. with human-Mus musculus monoclonal MAAP-9001 ?-chain, dimer, thioether with N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)
Common Name
English
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NCI_THESAURUS
C151967
PRIMARY
SMS_ID
300000020633
PRIMARY
CAS
2238831-60-0
PRIMARY
USAN
LM-52
PRIMARY
FDA UNII
GD2OWY1DTK
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
2
ACTIVE MOIETY
GD2OWY1DTK
Datopotamab Deruxtecan
METABOLITE ACTIVE (PARENT)
OQM5SD32BQ
N-[(1S,9S)-9-Ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]-2-hydroxyacetamide